Acquired vancomycin resistance in clinically relevant pathogens. - Wikidata - awgldk - TriplyDB

Acquired vancomycin resistance in clinically relevant pathogens.

Acquired vancomycin resistance in clinically relevant pathogens.

http://www.wikidata.org/entity/Q37277083

about

Acquired inducible antimicrobial resistance in Gram-positive bacteria Molecular basis of antibiotic multiresistance transfer in Staphylococcus aureus Solonamide B inhibits quorum sensing and reduces Staphylococcus aureus mediated killing of human neutrophils Binaphthyl-anchored antibacterial tripeptide derivatives with hydrophobic C-terminal amino acid variations.The rise of the Enterococcus: beyond vancomycin resistance.Development of quorum-based anti-virulence therapeutics targeting Gram-negative bacterial pathogens.Vancomycin-Resistant Enterococci and Bacterial Community Structure following a Sewage Spill into an Aquatic Environment.Strained cyclophane natural products: macrocyclization at its limits.The cell wall architecture of Enterococcus faecium: from resistance to pathogenesis.Development of antivirulence compounds: a biochemical review.Identification of vancomycin interaction with Enterococcus faecalis within 30 min of interaction time using Raman spectroscopy.Verbascoside Alleviates Pneumococcal Pneumonia by Reducing Pneumolysin Oligomers.In vitro activity of the new multivalent glycopeptide-cephalosporin antibiotic TD-1792 against vancomycin-nonsusceptible Staphylococcus isolates.Biogenic tellurium nanorods as a novel antivirulence agent inhibiting pyoverdine production in Pseudomonas aeruginosa.Terrein is an inhibitor of quorum sensing and c-di-GMP in Pseudomonas aeruginosa: a connection between quorum sensing and c-di-GMP.

P2860

Q27027012-03340A7A-8E40-4144-BBA0-31FF1C2308DC Q27676045-C5971FE7-9CC1-464A-B0E7-A426F141B2E6 Q28538518-D8EF2450-D96C-43D0-8841-25E62783D1D6 Q36281200-DDF89F69-AC8C-4F0C-B991-8C9D428898AC Q36752156-BB1C3BC0-F2C6-4D05-A075-E1A8D79D28AF Q37139191-B959DD81-4034-4AA9-B3FA-6E87C48CDF6E Q37224121-7AB7EBFC-1143-4C77-92D0-F380A2E8D71B Q38021350-93C473E2-3905-4936-AF18-F748C38D3F1A Q38125495-437364E3-66DA-427D-9CD6-D331DDAB616B Q38293001-04D26DBC-FBE6-4524-AADF-2C4620D7CB69 Q40672138-5A5D72E2-219B-478D-81FA-9ADC6CD216C7 Q40858891-F654B19B-B365-4051-861F-302114006BAD Q41837870-34D8D190-C31F-4CAC-B30D-00917E4169A0 Q46845402-54328406-F4EB-45C5-AE62-5851331C751D Q55265092-DB7041B5-3E8B-40AD-B033-A83B2AD7A6A9

P2860

Acquired vancomycin resistance in clinically relevant pathogens.

http://www.wikidata.org/entity/Q37277083

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on October 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Acquired vancomycin resistance in clinically relevant pathogens.

@en

Acquired vancomycin resistance in clinically relevant pathogens.

@nl

type

label

Acquired vancomycin resistance in clinically relevant pathogens.

@en

Acquired vancomycin resistance in clinically relevant pathogens.

@nl

prefLabel

Acquired vancomycin resistance in clinically relevant pathogens.

@en

Acquired vancomycin resistance in clinically relevant pathogens.

@nl

P1433

Q37277083-B1A8A32A-BBFA-44E4-8779-7C3B84EA503E

P1476

Q37277083-6EFF0B55-B4B6-47EA-BDB2-E635345A94D5

P2093

Q37277083-1091CE7C-D1F5-4061-A1DC-2691F0C93D3C

Q37277083-FBB573EF-9FC8-489E-961F-500A0E91C605

Q37277083-FD1693B3-F126-4C77-857D-80B88D7672EC

P2860

Q37277083-0153BFED-F405-4778-8B79-E7F5697EA438

Q37277083-039845AF-7C4A-4798-AD6B-FAC2E588E1F8

Q37277083-04A2416A-AA39-4A1C-B1BC-893E10634E2D

Q37277083-07DCAD69-6CC2-461E-994E-4538B0EF4293

Q37277083-08619E4F-6E5F-47B2-8B89-D42D33F0A839

Q37277083-08FB94C6-5CDA-41F5-BAF2-A6EDF46B920B

Q37277083-0C00F817-E3CD-4437-B61C-21A16D00132D

Q37277083-0FD7D9E2-6F48-4B00-9E96-FF4DDF0551DF

Q37277083-1011BCBA-F4FD-4003-AFA3-1CB34E72ACB1

Q37277083-10B06C2A-ECA8-405B-8BA0-053AE855E917

P304

Q37277083-7A50E2D1-C164-4A0B-AD0D-02A32361511A

P31

Q37277083-E96A592F-D5BD-4C56-926A-BC4FEA16131A

Q37277083-d7592cdb-dd42-4704-93ae-76ca92881010

P356

Q37277083-32E37888-1AEA-47EB-880D-A455FA6A2FDB

P433

Q37277083-CFC9E72C-04C1-4F3C-ADBA-7CE7F5BED322

P478

Q37277083-C6C20046-6BC8-4408-BD89-1BE6A1E57019

P577

Q37277083-31FA5353-6B53-4069-9DF1-18FCAC26D443

P698

Q37277083-33F8122E-1CF0-4104-AA07-B38E1E8BF4EF

P356

17460913.3.5.547

P1433

Future Microbiology

P1476

Acquired vancomycin resistance in clinically relevant pathogens.

@en

P2093

Birgit Strommenger

http://www.w3.org/2001/XMLSchema#string

Guido Werner

http://www.w3.org/2001/XMLSchema#string

Wolfgang Witte

http://www.w3.org/2001/XMLSchema#string

P2860

Role of Mobile DNA in the Evolution of Vancomycin-Resistant Enterococcus faecalis

The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA)

Prevalence and antimicrobial susceptibilities of bacteria isolated from blood cultures of hospitalized patients in the United States in 2002

Emerging resistance among bacterial pathogens in the intensive care unit--a European and North American Surveillance study (2000-2002)

Vancomycin resistance in gram-positive cocci

Vancomycin susceptibility within methicillin-resistant Staphylococcus aureus lineages

DNA microarray-based identification of genes associated with glycopeptide resistance in Staphylococcus aureus.

Insertion sequence-driven diversification creates a globally dispersed emerging multiresistant subspecies of E. faecium.

Different bacterial gene expression patterns and attenuated host immune responses are associated with the evolution of low-level vancomycin resistance during persistent methicillin-resistant Staphylococcus aureus bacteraemia.

Comparison of three PCR primer sets for identification of vanB gene carriage in feces and correlation with carriage of vancomycin-resistant enterococci: interference by vanB-containing anaerobic bacilli

P304

547-562

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/17460913.3.5.547

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2008-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18811239

http://www.w3.org/2001/XMLSchema#string